A Guide to Economic Recovery for Health System CFOs
How prioritizing long-term organizational changes immediately will ensure stability post-crisis.
How prioritizing long-term organizational changes immediately will ensure stability post-crisis.
It’s senior leadership’s job — including board members — to mitigate the effects of this pandemic.
Specialty drugs represent an opportunity to better serve patients, but also pose risks.
Men hold most (87 percent) of C-suite roles at healthcare’s top ranks. But why?
Oliver Wyman research examines whether consumers are using healthcare’s “new front door”, and if not, why not.
Oliver Wyman's 2018 Consumer Survey explores healthcare's supply and demand disconnect.
Women, healthcare's primary consumers, are 20 percent more likely than men are to express frustrations with the healthcare system.
Some of our 2018 predictions on consolidation, pharma, and investment came true, while others were less predictable.
As merger activity heightens, some leverage retail with pharma to meet consumer demand.
How pharmaceutical companies can better define, measure, and deliver value to patients.